✦ LIBER ✦

Problems with Drug-Eluting Coronary Stents — The FDA Perspective

✍ Scribed by Muni, Neal I.; Gross, Thomas P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory issues facing the development

✍ Boam, Ashley B 📂 Article 📅 2006 🏛 Expert Reviews 🌐 English ⚖ 56 KB

Drug-Eluting Coronary Stents in Patients

✍ Patrick Alexander; Shukri David; Peter A. McCullough 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 141 KB

What reimbursement for coronary revascul

✍ Rosanna Tarricone; Monia Marchetti; Mark Lamotte; Lieven Annemans; Peter de Jong 📂 Article 📅 2004 🏛 Springer 🌐 French ⚖ 358 KB

Unprotected Left Main Coronary Intervent

✍ MATTHEW J. PRICE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

The Current Status of Coronary Drug-Elut

✍ Chih-Wei Chen; Chin-Lon Lin 📂 Article 📅 2009 🏛 Tzu Chi Medical Center 🌐 Chinese ⚖ 201 KB

Use of IVUS guided coronary stenting wit

✍ Klersy, Catherine; Ferlini, Marco; Raisaro, Arturo; Scotti, Valeria; Balduini, A 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 696 KB